{"result": "(\"entity\"<|>ANOREXIA NERVIOSA<|>EVENT<|>Anorexia Nervosa (AN) is an eating disorder characterized by an intense fear of gaining weight and a distorted body image, leading to self-imposed starvation and excessive weight loss.)\n##\n(\"entity\"<|>GH<|>PERSON<|>Growth Hormone (GH) is a hormone that stimulates growth, cell reproduction, and regeneration in humans and other animals, often elevated in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>IGF-1<|>PERSON<|>Insulin-like Growth Factor 1 (IGF-1) is a hormone that plays an important role in childhood growth and continues to have anabolic effects in adults, often decreased in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>LEPTIN<|>PERSON<|>Leptin is a hormone that helps to regulate energy balance by inhibiting hunger, which is often altered in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>GHRH<|>PERSON<|>Gonadotropin-Releasing Hormone (GnRH) is a hormone responsible for the release of gonadotropins, which is dysregulated in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>SEROTONIN<|>PERSON<|>Serotonin is a neurotransmitter that affects mood and appetite, and its levels can be altered in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>NORADRENALINE<|>PERSON<|>Noradrenaline is a neurotransmitter involved in the body's response to stress, which can be affected in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>DOPAMINE<|>PERSON<|>Dopamine is a neurotransmitter that plays a role in reward and pleasure systems, and its levels can be altered in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>ENDOGENOUS OPIOIDS<|>PERSON<|>Endogenous opioids are peptides that bind to opioid receptors and can modulate pain and reward, which may be dysregulated in patients with Anorexia Nervosa.)\n##\n(\"entity\"<|>HYPOTHALAMUS<|>GEO<|>The hypothalamus is a region of the brain that controls various bodily functions, including hormone release, and is implicated in the dysregulation seen in Anorexia Nervosa.)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>GH<|>Patients with Anorexia Nervosa often exhibit elevated levels of Growth Hormone as a physiological response to starvation<|>7)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>IGF-1<|>Insulin-like Growth Factor 1 levels are typically decreased in patients with Anorexia Nervosa, indicating a metabolic disturbance<|>8)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>LEPTIN<|>Leptin levels are very low in patients with Anorexia Nervosa, correlating with their body weight<|>9)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>GHRH<|>Dysregulation of Gonadotropin-Releasing Hormone is a significant factor in the hormonal changes seen in Anorexia Nervosa<|>8)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>SEROTONIN<|>Alterations in serotonin levels are associated with the psychological aspects of Anorexia Nervosa<|>6)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>NORADRENALINE<|>Noradrenaline levels can be affected in patients with Anorexia Nervosa, influencing their stress response<|>5)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>DOPAMINE<|>Dopamine dysregulation may contribute to the reward and pleasure deficits seen in Anorexia Nervosa<|>5)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>ENDOGENOUS OPIOIDS<|>Endogenous opioids may be involved in the altered pain and reward pathways in Anorexia Nervosa<|>5)\n##\n(\"relationship\"<|>ANOREXIA NERVIOSA<|>HYPOTHALAMUS<|>The hypothalamus is implicated in the hormonal dysregulation observed in patients with Anorexia Nervosa<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ingoides podría deberse a una resistencia al cortisol o bien, como indican estudios más recientes, ser secundario a la malnutrición y a la ausencia de sustratos metabólicos. Sin embargo, los niveles elevados de cortisol pueden ser importantes en el desarrollo de osteopenia en estos pacientes.\n\nTambién se han descrito alteraciones en la leptina, si bien el papel exacto de esta hormona en los TCA re-\n\nquiere de un estudio más amplio. Los pacientes con AN presentan niveles muy bajos de leptina que guardan correlación con el peso corporal22. En un estudio, estos cambios se normalizaron con la recuperación nutricional, mientras que en otro no se modificaron con la renutrición a corto plazo. Tres estudios han correlacionado la amenorrea de las pacientes con AN con las alteraciones de la leptina. También se han descrito alteraciones en la leptina en pacientes con BN.\n\nLos pacientes con AN presentan niveles elevados de ghrelina en comparación con sujetos de peso normal, reflejando el estado de balance energético negativo23.\n\nLas alteraciones del eje tiroideo en la AN son consecuencia de la malnutrición. Se caracterizan por unos niveles en el rango bajo-normal de T4 y TSH, con niveles bajos de T3 y aumento de la rT3. Ello se debe al aumento de la conversión periférica de T4 en rT3 y a la disminución de la unión de la T4 a la globulina transportadora de tiroxina. Además, existe una disminución de la respuesta de la TSH a la TRH. Dado que estos cambios son adaptativos a la malnutrición y el ayuno, no está indicado el tratamiento con hormonas tiroideas. Las consecuencias clínicas incluyen pérdida de pelo, piel seca, hipotermia, bradicardia, hipometabolismo, etc., que son reversibles tras la renutrición.\n\nOtra de las complicaciones de la desnutrición en pacientes con AN es la alteración en la regulación de la glucosa. Estos pacientes pueden presentar hipoglucemia debido a la pérdida de las reservas de glucógeno hepático y al agotamiento de la gluconeogénesis como consecuencia de la progresiva pérdida de masa magra. Los niveles de insulina son apropiadamente bajos y la sensibilidad a la misma es normal. Como consecuencia de estas hipoglucemias pueden presentar crisis convulsivas y coma. Algunos autores han descrito una mayor prevalencia de los TCA entre los pacientes con diabetes tipo 1.\n\nLos pacientes con AN presentan frecuentemente retraso del crecimiento y del desarrollo como consecuencia de la malnutrición. Estas alteraciones pueden ser reversibles en muchos casos, aunque en ocasiones conducirán a una talla baja si la recuperación nutricional se produce tras el cierre de los cartílagos de crecimiento. Las manifestaciones hormonales consisten en elevación de los niveles de GH circulante con disminución de los niveles de IGF-1 debido a la resistencia a la GH. Además, disminuyen los niveles de la proteína transportadora de GH y se modifican los niveles de las proteínas transportadoras de IGF-1 (con aumento de la IGF-1BP1 e IGF-1BP2 y disminución de la IGF-1BP3)32. Estas alteraciones son reversibles con la renutrición.\n\nPero la manifestación endocrinológica más significativa de la AN es la amenorrea. Puede ser primaria o secundaria, dependiendo de si la paciente había tenido previamente la menarquia. Tradicionalmente se pensaba que la amenorrea era debida a la pérdida de peso y de masa grasa, con la consiguiente disminución en la producción de estrógenos como consecuencia de la\n---\n160      BLOQUE: ALTERACIONES DE LA ENERGÍA\n\ntransformación periférica de andrógenos en estrógenos en el tejido adiposo. Sin embargo, hoy sabemos que en más del 50% de las pacientes la amenorrea se produce antes de que la paciente haya perdido peso de forma significativa, por lo cual este es solo uno de los factores etiológicos implicados. El origen de la amenorrea es una disregulación hipotalámica, que conduce a un hipogonadismo hipogonadotrópico, con un patrón prepuberal y niveles circulantes muy bajos de estrógenos. Estas alteraciones hipotalámicas en la secreción de hormona liberadora de gonadotropinas (GnRH) se producen por las alteraciones de neurotransmisores (serotonina, noradrenalina, dopamina y opioides endógenos). La recuperación de la menstruación constituye un indicador muy importante de la curación de estas pacientes. El porcentaje del peso ideal necesario para la recuperación de las reglas en estas pacientes varía entre el 75 y el 115%, así como el porcentaje de grasa alrededor del 20%29. El 86% de las pacientes recuperan las reglas\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}